Treating generalised anxiety disorder.
Tonks
Alison
A
BMJ Unified, London WC1H 9JR.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000628:therapy*; D002243:Carbolines / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D006801:Humans; D006919:Hydroxyzine / Q000627:therapeutic use; D020901:Kava; D012064:Relaxation Therapy
D000319:Adrenergic beta-Antagonists; D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D002243:Carbolines; D006919:Hydroxyzine; C062769:abecarnil